期刊文献+

子宫内膜癌患者腹腔细胞学阳性的临床意义及对预后的影响 被引量:17

Clinical implications of positive peritoneal cytology in endometrial cancer
原文传递
导出
摘要 目的探讨子宫内膜癌患者腹腔细胞学阳性的临床意义及对预后的影响。方法对1996年1月至2008年12月复旦大学附属肿瘤医院收治的315例子宫内膜癌患者的临床病理资料进行回顾性分析,所有患者均行手术治疗,且均行术中腹水或腹腔冲洗液细胞学检查。对与腹腔细胞学阳性相关的因素,采用相关分析法进行分析;对影响子宫内膜癌患者预后的因素,采用log—rank检验进行单因素分析,采用Cox回归法进行多因素分析。结果(1)315例子宫内膜癌患者中,30例(9.5%)患者腹腔细胞学阳性。腹腔细胞学阳性与多个子宫内高危因素包括病理类型(P=0.013)、手术病理分期(P=0.000)、肌层浸润(P=0.012)、脉管浸润(P=0.012),以及多个子宫外转移危险因素包括子宫浆膜层侵犯(P=0.004)、宫颈受累(P=0.016)、附件转移(P=0.000)和大网膜转移(P=0.000)明显相关,而与病理分级(P=0.152)、淋巴结转移(P=0.066)无明显相关性。(2)315例子宫内膜癌患者的3年总生存率和3年无疾病进展生存率分别为93.0%和85.5%。单因素分析显示,腹腔细胞学阳性及不同手术病理分期、病理类型、肌层浸润深度、病理分级和脉管浸润是影响子宫内膜癌患者预后的危险因素(P〈0.05);多因素分析显示,手术病理分期、肌层浸润深度是影响子宫内膜癌患者预后的独立危险因素(P〈0.05)。30例腹腔细胞学阳性患者中,无高危因素患者的3年生存率和3年无疾病进展生存率均显著高于有高危因素者(P〈0.05);进一步分析显示,腹腔细胞学阳性是影响晚期(Ⅲ~Ⅳ期)子宫内膜癌患者预后的独立危险因素(P=0.006)。结论腹腔细胞学阳性与多个子宫内高危因素和子宫外转移危险因素密切相关,是影响晚期子宫内膜癌患者预后的独立危险因素。因此,腹水细胞学检查应继续作为全面分期手术的步骤之一,并将结果单独进行报告,是十分有必要的。 Objective To evaluate the clinical significance of positive peritoneal cytology in patients with endometrial cancer. Methods The records of 315 patients with endometrial cancer who were operated at Cancer Hospital, Fudan University between January 1996 and December 2008 were reviewed. Peritoneal cytology were performed and diagnosed in all patients. Factors related with peritoneal cytology were analyzed by correlation analysis. Log-rank test and Cox regression test was used for the analysis of prognosis, respectively. Results ( 1 ) Peritoneal cytology were positive in 30 ( 9.5% ) patients. Positive peritoneal cytology was associated with pathological subtype (P = 0. 013 ), stage (P = 0. 000 ), myometrial invasion ( P = O. 012), lymph-vascular space invasion ( P = 0. 012 ), serosal involvement ( P = 0. 004 ), cervical involvement ( P = 0. 016 ), adnexal involvement ( P = O. 000 ), and omental involvement ( P = 0. 000 ), with no association with grade (P = 0. 152) and lymph node metastasis ( P = 0. 066 ). ( 2 ) Three-year overall survival (OS) and progression-free survival(PFS) were 93.0% and 85.5% ,respectively. Positive peritoneal cytology, surgical stage, pathological subtype, myometrial invasion, grade, and lymph-vascular space invasion were significantly associated with worse prognosis by univariate analysis ( P 〈 0. 05 ), while only surgical-pathology stage and myometrial invasion were independent prognostic factors by multivariate analysis (P 〈 0. 05). For 30 cases with positive peritoneal cytology, the patients with no high risk factors shown significantly prognoses better than those with any risk factors. The results shown that for patients with late stage (stage Ⅲ~Ⅳ) endometrial cancer with positive peritoneal cytology was significantly associated with the worse OS and PFS by multivariate analysis (P = 0. 006). Conclusions Positive peritoneal cytology was associated with serosal involvement, cervical involvement, adnexal involvement, omental involvement, and late stage. Therefore, peritoneal cytology should be performed and reported separately as a part of full surgical staging procedure.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2011年第8期595-599,共5页 Chinese Journal of Obstetrics and Gynecology
基金 上海市科学技术委员会科研计划(08411961900) 复旦大学医学院青年骨干科研启动基金(09L-29)
关键词 子宫内膜肿瘤 细胞诊断学 腹水液 预后 Endometrial neoplasms Cytodiagnosis Ascitic fluid Prognosis
  • 相关文献

参考文献12

  • 1Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet,2009,105:103- 104.
  • 2Milosevic MF, Dembo AJ, Thomas GM. The clinical significance of malignant peritoneal cytology in stage Ⅰ endometrial carcinoma. Int J Gyneeol Cancer,1992,2:225-235.
  • 3McLellan R, Dillon MB, Currie JL, et al. Peritoneal cytology in endometrial cancer: a review. Obstet Gynecol Surv, 1989,dd.: 711-719.
  • 4Havrilesky LJ, Cragnn JM, Calingaert B, et al. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage ⅢA endometrial cancer. Gynecol Oneol,2007, 104:401-405.
  • 5Gu M, Shi W, Barakat RR, et al. Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation. Acta Cyto1,2000 ,44 :783-789.
  • 6李隆玉,曾四元,万磊,敖梅红.子宫内膜癌卵巢转移危险因素的探讨[J].中华妇产科杂志,2008,43(5):352-355. 被引量:11
  • 7Taskiran C, Yuce K, Geyik PO, et al. Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer. Int J Gynecol Cancer, 2006,16 : 1342-1347.
  • 8Fujiwara H, Saga Y, Takahashi K, et al. Omental metastases in clinical stage Ⅰ endometrioid adenocarcinoma. Int J Gynecol Cancer,2008,18 : 165-167.
  • 9Takeshima N, Nishida H, Tabata T, et al. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol,2001,82:470-473.
  • 10Santala M, Talvensaari-Mattila A, Kauppila A. Peritoneal cytology and preoperative serum CA125 level are important prognostic indicators of overall survival in advanced endometrial cancer. Anticaneer Res,2003,23:3097-3103.

二级参考文献16

  • 1周凤智,陈毅男,张国楠.子宫内膜癌卵巢转移临床病理分析[J].四川医学,2005,26(1):42-44. 被引量:8
  • 2李均,杨孝军,高树生,罗岳西.临床Ⅰ期子宫内膜癌患者的卵巢转移问题[J].现代肿瘤医学,2006,14(1):80-81. 被引量:4
  • 3尹雪彬,沈铿,郎景和.子宫内膜癌的病理分类、治疗及预后影响因素的现代观[J].中华妇产科杂志,1996,31(8):508-511. 被引量:23
  • 4刘新民,赵晶,万小平,吴强.子宫内膜癌手术范围的前瞻性临床研究[J].中华妇产科杂志,1996,31(9):548-550. 被引量:18
  • 5郎景和 吴鸣 连丽娟 主编.子宫内膜癌的临床表现与治疗[A].连丽娟,主编.林巧稚妇科肿瘤学.第3版[C].北京:人民卫生出版社,1999.365-369.
  • 6Benshushan A. Endometrial adenocareinoma in young patients: evaluation and fertility-preserving treatment. Eur J Obstet Gynecol Reprod Biol, 2004, 117: 132-137.
  • 7Evans-Metealf ER, Brooks SE, Reale FR, et al. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol, 1998,91 : 349 -354.
  • 8Young RL, Scully RE. Metastatic tumor of the ovary//Kurman RJ. Blaustein's pathology of the female genital tract. 3rd ed. New York : Springer, 1987:742-746.
  • 9Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 case. Hum Pathol, 1985,16 : 28-34.
  • 10吴瑞芳.绝经及卵巢切除前后卵巢与外周静脉血中甾体激素的变化[J].中华妇产科杂志,1988,23:338-340.

共引文献10

同被引文献107

  • 1李奎,温宏武,陶霞,郭燕燕.单纯腹腔细胞学阳性子宫内膜癌Ⅲa期患者的预后[J].中国妇产科临床杂志,2003,4(1):31-33. 被引量:2
  • 2李斌,章文华,吴令英,李淑敏.子宫内膜癌腹腔液细胞学阳性的临床意义[J].肿瘤防治杂志,2003,10(12):1299-1301. 被引量:6
  • 3马绍康,吴令英,高菊珍.子宫内膜癌ⅢA期单纯腹腔液细胞学阳性术后辅助治疗的意义[J].中国肿瘤临床,2007,34(14):822-825. 被引量:3
  • 4杨越波,李小毛,向阳.子宫肿瘤[M].北京:人民军医出版社,2011:193.
  • 5Shepherd JH. Revised FIGO staging for gynecological cancer[J]. Br J Obstet Gynecol, 1989,96 : 889-892.
  • 6Creasman W. Revised FIGO staging for carcinoma of the endometrium[J]. Inter J Gynecol Obst,2009,105(2) : 109.
  • 7Oscar Lin. Challenges in the Interpretation of Peritoneal Cytologic Specimens[J]. Arch Pathol Lab Med, 2009,133 (5) : 739-742.
  • 8Shield P. Peritoneal washing cytology[J]. Cytopathology, 2004,15 (2) : 131-141.
  • 9Mlyncek M ,Uharcek. Peritoneal cytology in endometrial cancer[J]. Neoplasma, 2005,52 ( 2 ) : 103 - 108.
  • 10Takeshima N,Nishida H,Tbbata T,et al. Peritoneal cytology in en- dometrial cancer:enhancement of other prognostic indicators[J]. Gynecol Oncol, 2001,82 : 470-473.

引证文献17

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部